Skip to content Skip to main menu Skip to utility menu

Drug safety notice: Methylprednisolone injections

January 21, 2021

There is currently insufficient supply in the UK of all strengths of Methylprednisolone injections. We urge clinicians to review all patients on Methylprednisolone for acute respiratory distress syndrome in critically ill COVID-19 patients and switch to an alternative steroid.

Please see methylpred shortage information sheet for further details.

For more information please contact the pharmacy department (City ext. 5263, Sandwell ext. 3783).